Kala Biopharmaceuticals Submits Form 144 Filing: An Insight into the Company and its Latest Disclosure
In a recent SEC filing, KALA Pharmaceuticals, Inc. (0001479419) submitted a Form 144. This form is typically filed by company insiders or affiliates to register their intent to sell restricted securities. While the filing of a Form 144 does not necessarily indicate immediate sales of the securities, it provides transparency to the market about potential future sales.
KALA Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies for eye diseases. Their proprietary technology allows for the delivery of therapeutic agents to the eye in a way that enhances drug penetration and retention. To learn more about KALA Pharmaceuticals, Inc., visit their website at https://www.kalarx.com/.
Overall, the submission of a Form 144 by KALA Pharmaceuticals, Inc. signals a potential upcoming sale of restricted securities by insiders or affiliates of the company. Investors and market watchers may keep an eye on any future developments related to this filing to gauge the sentiment and potential impact on the company’s stock.
Read More:
Kala Biopharma Inc. Submits Form 144 to SEC – Find Out More About the Filing
